Welcome to CDC Stacks | Whole Blood Gene Expression Analyses in Patients With Single Versus Recurrent Venous Thromboembolism - 33606 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Whole Blood Gene Expression Analyses in Patients With Single Versus Recurrent Venous Thromboembolism
Filetype[PDF - 1.11 MB]


Details:
  • Pubmed ID:
    21737128
  • Pubmed Central ID:
    PMC3726737
  • Description:
    Introduction

    Venous thromboembolism may recur in up to 30% of patients with a spontaneous venous thromboembolism after a standard course of anticoagulation. Identification of patients at risk for recurrent venous thromboembolism would facilitate decisions concerning the duration of anticoagulant therapy.

    Objectives

    In this exploratory study, we investigated whether whole blood gene expression data could distinguish subjects with single venous thromboembolism from subjects with recurrent venous thromboembolism.

    Methods

    40 adults with venous thromboembolism (23 with single event and 17 with recurrent events) on warfarin were recruited. Individuals with antiphospholipid syndrome or cancer were excluded. Plasma and serum samples were collected for biomarker testing, and PAXgene tubes were used to collect whole blood RNA samples.

    Results

    D-dimer levels were significantly higher in patients with recurrent venous thromboembolism, but P-selectin and thrombin-antithrombin complex levels were similar in the two groups. Comparison of gene expression data from the two groups provided us with a 50 gene probe model that distinguished these two groups with good receiver operating curve characteristics (AUC 0.75). This model includes genes involved in mRNA splicing and platelet aggregation. Pathway analysis between subjects with single and recurrent venous thromboembolism revealed that the Akt pathway was up-regulated in the recurrent venous thromboembolism group compared to the single venous thromboembolism group.

    Conclusions

    In this exploratory study, gene expression profiles of whole blood appear to be a useful strategy to distinguish subjects with single venous thromboembolism from those with recurrent venous thromboembolism. Prospective studies with additional patients are needed to validate these results.

  • Document Type:
  • Collection(s):
  • Funding:
    R21 DK080994/DK/NIDDK NIH HHS/United States
    R21DK080994/DK/NIDDK NIH HHS/United States
    T32-HL007538/HL/NHLBI NIH HHS/United States
    U54 HL077878/HL/NHLBI NIH HHS/United States
    U54-HL077878/HL/NHLBI NIH HHS/United States
    UO1-DD000014/DD/NCBDD CDC HHS/United States
No Related Documents.
You May Also Like: